TrialBMJ (Clinical research ed.)2026

Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR).

Timothy L Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.